Nicotine therapeutic benefits: Difference between revisions
Richardpruen (talk | contribs) Added COVID transmission studies (3) |
|||
| Line 1,523: | Line 1,523: | ||
===2023 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849855/ Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet]=== | ===2023 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849855/ Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet]=== | ||
=== The following articles address the possible transmission of the SARS CoV 2 virus (and other pathogens) through vaping exhalations. We show that the latter are extremely weak transmission vehicles. === | |||
* 2022: [https://link.springer.com/article/10.1007/s11356-022-20499-1 Analytic modeling and risk assessment of aerial transmission of SARS-CoV-2 virus through vaping expirations in shared micro-environments] | |||
* 2021: [https://doi.org/10.3390/ijerph18041437 Aerial transmission of the SARS-CoV-2 virus through environmental e-cigarette aerosol: implications for public policies.] | |||
* 2021: [http://doi.org/10.3390/app11146355 Modeling Aerial Transmission of Pathogens (Including the SARS-CoV-2 Virus) through Aerosol Emissions from E-Cigarettes.] | |||
=== 2022: [https://assets.researchsquare.com/files/rs-1062121/v1/fb8f5195-4cce-470f-9e09-e752fae3c931.pdf?c=1642705044 Part One: Abuse Liability of Vuse Solo Relative To Combustible Cigarettes And Nicotine Gum] === | === 2022: [https://assets.researchsquare.com/files/rs-1062121/v1/fb8f5195-4cce-470f-9e09-e752fae3c931.pdf?c=1642705044 Part One: Abuse Liability of Vuse Solo Relative To Combustible Cigarettes And Nicotine Gum] === | ||